WuXi XDC Cayman Inc. and BioDlink International Company Limited have provided an update regarding the proposed acquisition of all issued shares of TOT BIOPHARM International Co. Ltd., excluding those already owned or agreed to be acquired by the offeror and its concert parties. The companies announced a delay in the despatch of the composite document relating to the transaction. Further details, including the recommendations of the Independent Board Committee and the advice of the Independent Financial Adviser, will be provided in the forthcoming composite document.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOT BIOPHARM International Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260204-12014858), on February 04, 2026, and is solely responsible for the information contained therein.